First Trust Advisors LP Cuts Holdings in Milacron Holdings Corp (MCRN)

Share on StockTwits

First Trust Advisors LP lowered its stake in Milacron Holdings Corp (NYSE:MCRN) by 50.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 57,232 shares of the industrial products company’s stock after selling 57,203 shares during the quarter. First Trust Advisors LP owned about 0.08% of Milacron worth $1,159,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Macquarie Group Ltd. acquired a new stake in shares of Milacron in the second quarter valued at approximately $100,000. Paloma Partners Management Co acquired a new stake in shares of Milacron in the second quarter valued at approximately $324,000. California Public Employees Retirement System acquired a new stake in shares of Milacron in the second quarter valued at approximately $344,000. Trexquant Investment LP raised its holdings in shares of Milacron by 76.9% in the second quarter. Trexquant Investment LP now owns 18,887 shares of the industrial products company’s stock valued at $358,000 after purchasing an additional 8,213 shares during the last quarter. Finally, OppenheimerFunds Inc. raised its holdings in shares of Milacron by 46.5% in the second quarter. OppenheimerFunds Inc. now owns 19,399 shares of the industrial products company’s stock valued at $367,000 after purchasing an additional 6,153 shares during the last quarter.

A number of analysts have recently issued reports on MCRN shares. KeyCorp lowered their price objective on shares of Milacron from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 26th. ValuEngine downgraded shares of Milacron from a “hold” rating to a “sell” rating in a report on Thursday, October 18th. Finally, Zacks Investment Research downgraded shares of Milacron from a “hold” rating to a “sell” rating in a report on Friday, October 12th. Two research analysts have rated the stock with a sell rating and two have given a buy rating to the company. Milacron has an average rating of “Hold” and a consensus price target of $23.00.

Shares of MCRN opened at $12.45 on Friday. The firm has a market cap of $956.80 million, a P/E ratio of 7.37, a PEG ratio of 1.01 and a beta of 1.28. Milacron Holdings Corp has a 1-year low of $12.44 and a 1-year high of $22.62.

Milacron (NYSE:MCRN) last issued its earnings results on Thursday, October 25th. The industrial products company reported $0.43 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.02. The business had revenue of $308.30 million for the quarter, compared to the consensus estimate of $320.00 million. Milacron had a net margin of 3.07% and a negative return on equity of 87.32%. Analysts anticipate that Milacron Holdings Corp will post 1.67 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece was first posted by BBNS and is owned by of BBNS. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://baseballnewssource.com/2018/12/08/first-trust-advisors-lp-cuts-holdings-in-milacron-holdings-corp-mcrn/3063848.html.

Milacron Company Profile

Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids).

Recommended Story: What is Liquidity?

Institutional Ownership by Quarter for Milacron (NYSE:MCRN)

Receive News & Ratings for Milacron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milacron and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.